---
title: "NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual"
ocid: "ocds-h6vhtk-031f20"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-031f20"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-031f20.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-031f20.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2022-08-11"
---

# NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-031f20

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-031f20)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-031f20.json)

## Summary

The National Health Service (NHS) England has awarded a contract for a Framework Agreement for London, Branded Medicines. The procurement process was initiated through a tender with the reference number CM/PHR/20/5614. The framework covers two lots: Tranche A and Annual Tranche, with respective periods from September 2022 to August 2024 and September 2022 to August 2023. The NHS England as the buyer has selected multiple suppliers for each lot.

This tender for the NHS Framework Agreement presents significant business opportunities for pharmaceutical companies and suppliers of branded medicines. Businesses in the pharmaceutical products industry, both large-scale and small and medium-sized enterprises, can compete by offering their products or services in response to this procurement. The open procedure procurement method allows fair competition among suppliers, with options for extending the framework agreement, providing a potential pathway for sustained business growth and collaboration.

## Notice

NHS London Branded Medicines - Tranche A 

Offer reference number: CM/PHR/20/5614

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

### Lot Information

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A

NHS London Branded Medicines - Tranche A 

Offer reference number: CM/PHR/20/5614

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Further to II.2.5 - Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for LONDON Branded Medicines - Annual Tranche

NHS London Branded Medicines - Tranche A 

Offer reference number: CM/PHR/20/5614

CM/PHR/20/5614/01 - NHS Framework for LONDON Branded Medicines - Tranche A. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5614/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Further to II.2.5 - Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/022184-2022 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 11 Aug 2022 |
| Submission deadline | 12 Apr 2022 |
| Future notice date | Not specified |
| Award date | 14 Jul 2022 |
| Contract period | 31 Aug 2022 - 31 Aug 2023 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £276,524,326 |
| Lots value | £276,524,326 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Additional buyers | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) |
| Locality | RUNCORN |
| Post town | Warrington |
| Postcode | WA7 2ES |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Little London & Woodhouse |
| Westminster constituency | Leeds Central and Headingley |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 28 |
| Supplier names | ABBVIE; ACCORD-UK; ALMIRALL; AMGEN; ASTRAZENECA; AVENTIS PHARMA LTD T/A SANOFI; CELLTRION HEALTHCARE UNITED KINGDOM; ELI LILLY; GEDEON RICHTER; GLAXOSMITHKLINE; IPSEN; JANSSEN-CILAG; MERCK SERONO; MERCK SHARPE AND DOHME (UK; MERZ; NOVO NORDISK; ORGANON PHARMACEUTICALS; PFIZER; PHARMACOSMOS; ROCHE PRODUCTS; SANDOZ; SOBI (SWEDISH ORPHAN BIOVITRUM; TAKEDA; TEVA; THORNTON AND ROSS; UCB PHARMA LTD (PRIMARY; VIFOR PHARMA; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 11 Aug 2022 at 14:08 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/022184-2022
- 8 Mar 2022 at 11:40 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/006279-2022

## Notice URLs

- http://health.atamis.co.uk
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk/
- https://www.gov.uk/courts-tribunals

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-031f20. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-031f20.json.